Scholars Central

CommentaryPublished 29 Jul 2023

Current and Emerging Pharmacological Dementia Treatment Options

Authors: Roest Simons

Department of Bioinformatics and Molecular Genetics and Center for Biological Systems Analysis, Netherlands

Journal of Dementia

Volume 7 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dementia is a progressive neurodegenerative disorder that affects millions of people worldwide, causing cognitive decline, memory loss, and behavioral changes. While there is no cure for dementia, pharmacological treatments aim to manage symptoms and slow down disease progression. This article provides an overview of the current pharmacological options, including cholinesterase inhibitors and NMDA receptor antagonists, commonly used in dementia treatment. Additionally, it explores emerging therapies, such as anti-amyloid therapies, tau protein stabilizers, anti-inflammatory drugs, and neuroprotective agents, which hold promise for modifying the underlying pathology of dementia. Continued research in pharmacological interventions is crucial for developing more effective treatments and improving the lives of individuals affected by dementia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Dementia.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Dementia
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Roest Simons”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels